Currently holds a position at Harpoon Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | Harpoon Therapeutics Inc | May 1, 2017 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-04-25 | 2022-04-21 |
Pyxis Oncology Inc
(PYXS)
|
S Sale |
1,745,761
-100.0%
3.055,324,571 USD |
1,745,761 -100.0% | 3.05 | 5,324,571 USD | |
2021-10-15 | 2021-10-13 |
Pyxis Oncology Inc
(PYXS)
|
B Purchase |
312,500
+21.8%
16.005,000,000 USD |
312,500 +21.8% | 16.00 | 5,000,000 USD | |
2020-03-16 | 2020-03-16 |
Imara Inc
(IMRA)
|
B Purchase |
187,500
+13.7%
16.003,000,000 USD |
187,500 +13.7% | 16.00 | 3,000,000 USD | |
2019-12-10 | 2019-12-06 |
Harpoon Therapeutics Inc
(HARP)
|
S Sale |
47,752
-1.7%
19.15914,222 USD |
47,752 -1.7% | 19.15 | 914,222 USD | |
2019-02-14 | 2019-02-12 |
Harpoon Therapeutics Inc
(HARP)
|
B Purchase |
428,571
+17.4%
14.005,999,994 USD |
428,571 +17.4% | 14.00 | 5,999,994 USD |